Genmark Diagnostics reported $1.05B in Market Capitalization for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 205.99B 6.31B
Accelerate Diagnostics AXDX:US 509.4M 72.73M
Agilent A:US $ 38.74B 2.38B
Bruker BRKR:US $ 9.74B 1.45B
Danaher DHR:US $ 191.42B 30.92B
Exact Sciences EXAS:US $ 21.33B 957.64M
Genmark Diagnostics GNMK:US $ 1.05B 37.91M
Hologic HOLX:US $ 17.1B 2.07B
Illumina ILMN:US $ 56.07B 2.05B
Laboratory Of America LH:US $ 24.89B 5.07B
Luminex LMNX:US $ 1.51B 433.34M
Mesa Laboratories MLAB:US $ 1.25B 217.57M
Myriad Genetics MYGN:US $ 1.49B 513.08M
Nanostring Technologies NSTG:US $ 2.93B 17.58M
Orasure Technologies OSUR:US $ 847.78M 88.49M
Oxford Immunotec Global OXFD:US 303.75M 33.67M
Pacific Biosciences Of California PACB:US $ 6.43B 1.61B
Perkinelmer PKI:US $ 17.31B 2.93B
Quest Diagnostics DGX:US $ 17.24B 398.95M
Quidel QDEL:US $ 5.44B 2.11B
Siemens SIE:GR 119B 19.11B
Thermo Fisher Scientific TMO:US $ 198.27B 18.91B
Veracyte VCYT:US $ 3.6B 767.84M
Waters WAT:US $ 17.64B 2.28B